Crossmark

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study

Crossref DOI link: https://doi.org/10.1007/s00381-015-2725-3

Published Online: 2015-05-01

Published Print: 2015-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hoffman, Lindsey M.

Fouladi, Maryam

Olson, James

Daryani, Vinay M.

Stewart, Clinton F.

Wetmore, Cynthia

Kocak, Mehmet

Onar-Thomas, Arzu

Wagner, Lars

Gururangan, Sridharan

Packer, Roger J.

Blaney, Susan M.

Gajjar, Amar

Kun, Larry E.

Boyett, James M.

Gilbertson, Richard J.
License Information

Text and Data Mining valid from 2015-05-01